NasdaqCM - Nasdaq Real Time Price USD

Nephros, Inc. (NEPH)

Compare
1.4479 -0.0121 (-0.83%)
As of 10:44 AM EDT. Market Open.
Loading Chart for NEPH
DELL
  • Previous Close 1.4600
  • Open 1.4700
  • Bid --
  • Ask --
  • Day's Range 1.4479 - 1.4700
  • 52 Week Range 1.4300 - 4.0400
  • Volume 2,082
  • Avg. Volume 13,446
  • Market Cap (intraday) 15.267M
  • Beta (5Y Monthly) 1.18
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1200
  • Earnings Date Nov 6, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

www.nephros.com

31

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NEPH

View More

Performance Overview: NEPH

Trailing total returns as of 10/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NEPH
58.15%
S&P 500
22.56%

1-Year Return

NEPH
11.71%
S&P 500
35.08%

3-Year Return

NEPH
81.88%
S&P 500
33.96%

5-Year Return

NEPH
84.35%
S&P 500
96.81%

Compare To: NEPH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NEPH

View More

Valuation Measures

Annual
As of 10/11/2024
  • Market Cap

    15.39M

  • Enterprise Value

    13.89M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.11

  • Price/Book (mrq)

    1.94

  • Enterprise Value/Revenue

    1.01

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -9.40%

  • Return on Assets (ttm)

    -7.96%

  • Return on Equity (ttm)

    -15.61%

  • Revenue (ttm)

    13.77M

  • Net Income Avi to Common (ttm)

    -1.29M

  • Diluted EPS (ttm)

    -0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.08M

  • Total Debt/Equity (mrq)

    19.93%

  • Levered Free Cash Flow (ttm)

    -235.88k

Research Analysis: NEPH

View More

Company Insights: NEPH

Research Reports: NEPH

View More

People Also Watch